Epsilon M&A Deal Report - Anteis
Transaction Multiples for the Valuation of Private Companies
Merz / Anteis
No EMAT :
78456
Announced Date :
08/11/2013
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Merz
Target :
Anteis
Country :
Switzerland
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Co-founded in March 2003 by Gilles Bos, Silvia Scherrer and Olivier Benoit , Anteis is engaged in the development, manufacture, and distribution of injectable medical devices based on biopolymer...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|||||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 31
| Date | Acquirer | Target | Country | Multiples | See details |
| 03/01/2014 | Sinclair IS Pharma | ObvieLine Laboratories | France | ** | 78446 |
| 04/06/2015 | Addtech | Mediplast | Sweden | *** | 78240 |
Source: Epsilon Research / EMAT
